Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A sequential procedure for a phase II efficacy trial in hypercholesterolemia.

K M Facey1

  • 1Department of Applied Statistics, University of Reading, United Kingdom.

Controlled Clinical Trials
|April 1, 1992
PubMed
Summary

This study introduces a flexible sequential trial design for hypercholesterolemia treatments, allowing early stopping for efficacy or futility. The triangular test enhances trial efficiency by enabling early conclusions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Statistical shortcomings in licensing applications.

Statistics in medicine·1998
Same author

The management of interim analyses in drug development.

Statistics in medicine·1998
Same author

Comparison of the spending function method and the Christmas tree correction for group sequential trials.

Journal of biopharmaceutical statistics·1996
Same author

An improved approximation for calculation of confidence intervals after a sequential clinical trial.

Statistics in medicine·1990
Same author

The impact that group sequential tests would have made on ECOG clinical trials.

Statistics in medicine·1990

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Cardiovascular Medicine

Background:

  • Hypercholesterolemia poses a significant cardiovascular risk.
  • Evaluating novel treatments requires efficient and flexible clinical trial designs.
  • Sequential testing methods offer advantages in trial monitoring and early decision-making.

Purpose of the Study:

  • To present the design of a phase II placebo-controlled trial for a new hypercholesterolemia treatment.
  • To utilize a sequential procedure, specifically the triangular test, for enhanced trial flexibility and early stopping capabilities.
  • To compare the accuracy of error rates for the triangular test under different parameterizations.

Main Methods:

  • A phase II placebo-controlled efficacy trial design for hypercholesterolemia.

Related Experiment Videos

  • Implementation of the triangular test, a sequential analysis method.
  • Primary response variable: reduction in total serum cholesterol (assumed normally distributed).
  • Parameterization of treatment difference using standardized means and direct means.

    • Main Results:

    • The triangular test allows for early stopping for both efficacy and futility, even when the null hypothesis is accepted.
    • Comparison of error rate accuracy between standardized mean difference and direct mean difference parameterizations.
    • The study details the statistical framework for sequential monitoring in hypercholesterolemia trials.

    Conclusions:

    • The triangular test provides a flexible and efficient approach for phase II hypercholesterolemia trials.
    • Sequential designs can optimize resource allocation and patient exposure in clinical research.
    • Accurate statistical parameterization is crucial for maintaining the integrity of sequential trial error rates.